Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2269969
Max Phase: Preclinical
Molecular Formula: C24H34ClN3O4
Molecular Weight: 464.01
Molecule Type: Small molecule
Associated Items:
ID: ALA2269969
Max Phase: Preclinical
Molecular Formula: C24H34ClN3O4
Molecular Weight: 464.01
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCOCCc1ccc(OCCN(C(C)=O)C(=O)c2c(Cl)c(C(C)(C)C)nn2C)c(C)c1
Standard InChI: InChI=1S/C24H34ClN3O4/c1-8-31-13-11-18-9-10-19(16(2)15-18)32-14-12-28(17(3)29)23(30)21-20(25)22(24(4,5)6)26-27(21)7/h9-10,15H,8,11-14H2,1-7H3
Standard InChI Key: OYGXYSMRUFLLDM-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 464.01 | Molecular Weight (Monoisotopic): 463.2238 | AlogP: 4.33 | #Rotatable Bonds: 9 |
Polar Surface Area: 73.66 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 1.02 | CX LogP: 4.60 | CX LogD: 4.60 |
Aromatic Rings: 2 | Heavy Atoms: 32 | QED Weighted: 0.52 | Np Likeness Score: -0.95 |
1. OBATA T, FUJII K, FUNAKI E, TSUTSUMIUTI K, OHOKA A, SUIZU S, KANETSUKI Y. (1999) Synthesis and Selective Bioactivity of New Pyrazolecarboxamide Derivatives, 24 (1): [10.1584/jpestics.24.33] |
Source(1):